Lombard Odier Asset Management (Switzerland)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,224
| Closed | -$776K | – | 498 |
|
|
2021
Q2 | $776K | Buy |
4,224
+297
| +8% | +$54.6K | 0.04% | 235 |
|
|
2021
Q1 | $600K | Buy |
+3,927
| New | +$600K | 0.04% | 218 |
|
|
2020
Q4 | – | Sell |
-8,325
| Closed | -$953K | – | 365 |
|
|
2020
Q3 | $953K | Buy |
+8,325
| New | +$953K | 0.1% | 147 |
|
|
2016
Q2 | – | Sell |
-444
| Closed | -$62K | – | 452 |
|
|
2016
Q1 | $62K | Hold |
444
| – | – | 0.01% | 388 |
|
|
2015
Q4 | $86K | Buy |
+444
| New | +$86K | 0.01% | 383 |
|
|
2015
Q2 | – | Sell |
-1,200
| Closed | -$209K | – | 464 |
|
|
2015
Q1 | $209K | Buy |
+1,200
| New | +$209K | 0.02% | 364 |
|
|
2014
Q4 | – | Sell |
-73,700
| Closed | -$12.2M | – | 751 |
|
|
2014
Q3 | $12.2M | Buy |
73,700
+72,689
| +7,190% | +$12.1M | 0.31% | 82 |
|
|
2014
Q2 | $157K | Buy |
+1,011
| New | +$157K | 0.02% | 418 |
|